Illumina

Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. To learn more, visit illumina.com and connect with us on Twitter, Facebook, LinkedIn, Instagram, TikTok and YouTube.

Health & Healthcare | Illumina

Children’s Hospital Colorado Delivers Precision Medicine to Kids

Jan 28, 2025 10:00 AM ET

Over the last 20 years, precision medicine has become the standard of care, but for many hospitals, the complexity of the process has made it challenging to integrate or manage efficiently and at scale.

Videos

Innovation & Technology | Illumina

Home Genetic Testing Might Save a Few of Your Cat's Nine Lives

Aug 16, 2022 10:00 AM ET

At a Silicon Valley conference in 2016, Anna Skaya attended a talk by the founder of 23andMe, who joked that someone should start a company for cat genetics testing called “23andMeow.”

Environment | Illumina

Breeding a More Resilient Yam in West Africa

Aug 1, 2022 10:00 AM ET

In many tropical countries, yams are known as the “king of crops.” Worldwide, they’re the fourth most utilized root and tuber crop—after potatoes, cassavas, and sweet potatoes—and they feed hundreds of millions of people.

Responsible Business & Employee Engagement | Illumina

Francis deSouza Recognized as 3BL Media's Responsible CEO of the Year for Innovation and ESG Integration

Oct 25, 2022 2:45 PM ET

Illumina CEO, Francis deSouza received the award for 3BL Media’s 2022 Responsible CEO of the Year: Innovation and ESG Integration.

Responsible Business & Employee Engagement | Illumina

In Our DNA: Suzanne Rohrback, Senior Staff Bioinformatics Scientist at Illumina

Oct 14, 2022 10:30 AM ET

As a scientist on Illumina’s Assay Research team in San Diego, Suzanne Rohrback works with colleagues to come up with new ways next-generation sequencing (NGS) can maximize insights from a sample—such as cells from a tumor or a tube of blood—extracting as much information about it as possible, as efficiently as possible.

Environment | Illumina

Minderoo Foundation and Illumina Commit $40M AUD To Apply Advanced Genomics to Marine Conservation

Aug 17, 2022 3:20 PM ET

Minderoo Foundation and Illumina, Inc. (NASDAQ: ILMN), today announced a 40 million Australian dollar (US $27.8 million) partnership that will leverage the power of genomics to accelerate scientific understanding of marine systems and help marine conservationists make informed decisions.

Innovation & Technology | Illumina

Home Genetic Testing Might Save a Few of Your Cat's Nine Lives

Aug 16, 2022 10:00 AM ET

At a Silicon Valley conference in 2016, Anna Skaya attended a talk by the founder of 23andMe, who joked that someone should start a company for cat genetics testing called “23andMeow.”

Environment | Illumina

Breeding a More Resilient Yam in West Africa

Aug 1, 2022 10:00 AM ET

In many tropical countries, yams are known as the “king of crops.” Worldwide, they’re the fourth most utilized root and tuber crop—after potatoes, cassavas, and sweet potatoes—and they feed hundreds of millions of people.

Responsible Business & Employee Engagement | Illumina

Francis deSouza Recognized as 3BL Media's Responsible CEO of the Year for Innovation and ESG Integration

Oct 25, 2022 2:45 PM ET

Illumina CEO, Francis deSouza received the award for 3BL Media’s 2022 Responsible CEO of the Year: Innovation and ESG Integration.

Responsible Business & Employee Engagement | Illumina

In Our DNA: Suzanne Rohrback, Senior Staff Bioinformatics Scientist at Illumina

Oct 14, 2022 10:30 AM ET

As a scientist on Illumina’s Assay Research team in San Diego, Suzanne Rohrback works with colleagues to come up with new ways next-generation sequencing (NGS) can maximize insights from a sample—such as cells from a tumor or a tube of blood—extracting as much information about it as possible, as efficiently as possible.